The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors
Open accessAbstract
The cystic fibrosis transmembrane conductance regulator (CFTR) protein is a cAMP-regulated epithelial Cl− channel that, when defective, causes cystic fibrosis. Screening of a collection of 100,000 diverse small molecules revealed four novel chemical classes of CFTR inhibitors with Ki < 10 μM, one of which (glycine hydrazides) had many active structural analogues. Analysis of a series of synthesized glycine hydrazide analogues revealed maximal inhibitory potency for N-(2-naphthalenyl) and 3,5-dibromo-2,4-dihydroxyphenyl substituents. The compound N-(2-naphthalenyl)-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene]glycine hydrazide (GlyH-101) reversibly inhibited CFTR Cl− conductance in <1 min. Whole-cell current measurements revealed voltage-dependent CFTR block by GlyH-101 with strong inward rectification, producing an increase in apparent inhibitory constant Ki from 1.4 μM at +60 mV to 5.6 μM at −60 mV. Apparent potency was reduced by lowering extracellular Cl− concentration. Patch-clamp experiments indicated fast channel closures within bursts of channel openings, reducing mean channel open time from 264 to 13 ms (−60 mV holding potential, 5 μM GlyH-101). GlyH-101 inhibitory potency was independent of pH from 6.5–8.0, where it exists predominantly as a monovalent anion with solubility ∼1 mM in water. Topical GlyH-101 (10 μM) in mice rapidly and reversibly inhibited forskolin-induced hyperpolarization in nasal potential differences. In a closed-loop model of cholera, intraluminal GlyH-101 (2.5 μg) reduced by ∼80% cholera toxin–induced intestinal fluid secretion. Compared with the thiazolidinone CFTR inhibitor CFTRinh-172, GlyH-101 has substantially greater water solubility and rapidity of action, and a novel inhibition mechanism involving occlusion near the external pore entrance. Glycine hydrazides may be useful as probes of CFTR pore structure, in creating animal models of CF, and as antidiarrheals in enterotoxic-mediated secretory diarrheas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
Almilaji, A., Szteyn, K., Fein, E., Pakladok, T., Munoz, C., Elvira, B., Towhid, S. T., Alesutan, I., Shumilina, E., Bock, C.-T., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350083 · Cited by 8,675
Regulation of the Voltage Gated K+ Channel Kv1.3 by Recombinant Human Klotho Protein
Almilaji, A., Honisch, S., Liu, G., Elvira, B., Ajay, S. S., Hosseinzadeh, Z., Ahmed, M., Munoz, C., Sopjani, M., & Lang, F. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368472 · Cited by 5,592
Ma, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16112 · Cited by 633
Self-citationMa, T., Thiagarajah, J. R., Yang, H., Sonawane, N. D., Folli, C., Galietta, L. J. V., & Verkman, A. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216112 · Cited by 536
Self-citationRole of CFTR in Airway Disease
PILEWSKI, J. M., & FRIZZELL, R. A. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s215 · Cited by 447
Pharmacology of CFTR Chloride Channel Activity
SCHULTZ, B. D., SINGH, A. K., DEVOR, D. C., & BRIDGES, R. J. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s109 · Cited by 282
Mechanism and cellular applications of a green fluorescent protein-based halide sensor
Jayaraman, S., Haggie, P., Wachter, R. M., Remington, S. J., & Verkman, A. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6047 · Cited by 264
Self-citationCell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists
Galietta, L. V. J., Jayaraman, S., & Verkman, A. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.5.c1734 · Cited by 213
Self-citationSheppard, D. N., & Robinson, K. A. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.333bh.x · Cited by 202
Cited by
A functional CFTR assay using primary cystic fibrosis intestinal organoids
Dekkers, J. F., Wiegerinck, C. L., de Jonge, H. R., Bronsveld, I., Janssens, H. M., de Winter-de Groot, K. M., Brandsma, A. M., de Jong, N. W. M., Bijvelds, M. J. C., Scholte, B. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3201 · Cited by 999
Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs
Rogers, C. S., Stoltz, D. A., Meyerholz, D. K., Ostedgaard, L. S., Rokhlina, T., Taft, P. J., Rogan, M. P., Pezzulo, A. A., Karp, P. H., Itani, O. A., et al. (2008) · Science · doi:10.1126/science.1163600 · Cited by 749
The ABC protein turned chloride channel whose failure causes cystic fibrosis
Gadsby, D. C., Vergani, P., & Csanády, L. (2006) · Nature · doi:10.1038/nature04712 · Cited by 703
CALCIUM-ACTIVATED CHLORIDE CHANNELS
Hartzell, C., Putzier, I., & Arreola, J. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.032003.154341 · Cited by 626
CFTR Function and Prospects for Therapy
Riordan, J. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142532 · Cited by 610
Metadata
- Authors
- Muanprasat, C., Sonawane, N. D., Salinas, D., Taddei, A., Galietta, L. J. V., & Verkman, A. S.
- Venue
- The Journal of General Physiology
- Publisher
- Rockefeller University Press
- Published
- 2004-07-26
- Volume
- 124
- Issue
- 2
- Pages
- 125-137
- ISSN
- 0022-1295 (ISSN-L)
- 1540-7748
- OpenAlex
- W1993860856
- Cited by
- 264
- References
- 23
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors. https://app.cochat.ai/papers/10.1085/jgp.200409059
- The paper
- Muanprasat, C., Sonawane, N. D., Salinas, D., Taddei, A., Galietta, L. J. V., & Verkman, A. S. (2004). Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors. The Journal of General Physiology. https://doi.org/10.1085/jgp.200409059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.